Minor
ZODIPSO · Tildrakizumab in Difficult-to-treat Areas in Psoriasis
Trial completed
Also in this update: Final enrollment: 160 participants (planned 120)
Clin4allNot specified NCT05938361 Registry history of NCT05938361 on ClinicalTrials.gov (opens the registry)